Cargando…
Targeted Toxin Gene Therapy Of Breast Cancer Stem Cells Using CXCR1 Promoter And bFGF 5′UTR
BACKGROUND: Breast cancer stem cells (BCSCs) are cells with a higher ability to metastasis and resistance to conventional treatments. They have a phenotype of (CD44high/CD24low) and the unlimited ability for proliferation. Development of strategies to target the BCSC population may lead to the estab...
Autores principales: | Moradian, Cobra, Rahbarizadeh, Fatemeh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6821057/ https://www.ncbi.nlm.nih.gov/pubmed/31695436 http://dx.doi.org/10.2147/OTT.S221223 |
Ejemplares similares
-
PE38-based gene therapy of HER2-positive breast cancer stem cells via VHH-redirected polyamidoamine dendrimers
por: Moradian, Cobra, et al.
Publicado: (2021) -
Regulation of bFGF gene expression and subcellular distribution of bFGF protein in adrenal medullary cells
Publicado: (1994) -
Expression of bFGF and VEGF in brain astrocytoma.
por: Shim, J. W., et al.
Publicado: (1996) -
bFGF promotes adipocyte differentiation in human mesenchymal stem cells derived from embryonic stem cells
por: Song, Xinghui, et al.
Publicado: (2014) -
Delivery of bFGF for Tissue Engineering by Tethering to the ECM
por: Suttinont, Chawapun, et al.
Publicado: (2015)